Clinical Trial Update: To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing CC-11050 for safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in discoid and subacute cutaneous lupus ery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Discoid Lupus Erythematosus
• Subacute Cutaneous Lupus Erythematosus

Drugs mentioned

• CC-11050

Snippet

Sponsor: Amgen | Conditions: Cutaneous Lupus Erythematosus | Phase 2 | Status: COMPLETED